Skip to main navigation Skip to search Skip to main content

Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology

  • Thomas M. Gorter
  • , Dirk J. van Veldhuisen
  • , Johann Bauersachs
  • , Barry A. Borlaug
  • , Jelena Celutkiene
  • , Andrew J.S. Coats
  • , Marisa G. Crespo-Leiro
  • , Marco Guazzi
  • , Veli Pekka Harjola
  • , Stephane Heymans
  • , Loreena Hill
  • , Mitja Lainscak
  • , Carolyn S.P. Lam
  • , Lars H. Lund
  • , Alexander R. Lyon
  • , Alexandre Mebazaa
  • , Christian Mueller
  • , Walter J. Paulus
  • , Burkert Pieske
  • , Massimo F. Piepoli
  • Frank Ruschitzka, Frans H. Rutten, Petar M. Seferovic, Scott D. Solomon, Sanjiv J. Shah, Filippos Triposkiadis, Rolf Wachter, Carsten Tschöpe, Rudolf A. de Boer*
*Corresponding author for this work
  • University Medical Centre Groningen
  • Hannover Medical School
  • Mayo Clinic Rochester, MN
  • Vilnius University
  • Monash University
  • University of Warwick
  • University of A Coruna
  • University of Milan
  • University of Helsinki
  • Maastricht University
  • Queen's University Belfast
  • General Hospital Murska Sobota
  • National Heart Centre Singapore
  • Karolinska University Hospital
  • National Heart and Lung Institute
  • Assistance publique – Hôpitaux de Paris
  • Universitätsspital Basel
  • VU University Medical Center
  • Charité – Universitätsmedizin Berlin
  • Guglielmo da Saliceto Hospital
  • University Hospital Zürich
  • University Medical Centre Utrecht
  • Clinical Center of Serbia
  • Harvard Medical School
  • Northwestern University
  • University Hospital of Larissa
  • University Hospital Leipzig
  • University of Groningen

Research output: Contribution to journalArticleAcademicpeer-review

319 Citations (Scopus)

Abstract

There is an unmet need for effective treatment strategies to reduce morbidity and mortality in patients with heart failure with preserved ejection fraction (HFpEF). Until recently, attention in patients with HFpEF was almost exclusively focused on the left side. However, it is now increasingly recognized that right heart dysfunction is common and contributes importantly to poor prognosis in HFpEF. More insights into the development of right heart dysfunction in HFpEF may aid to our knowledge about this complex disease and may eventually lead to better treatments to improve outcomes in these patients. In this position paper from the Heart Failure Association of the European Society of Cardiology, the Committee on Heart Failure with Preserved Ejection Fraction reviews the prevalence, diagnosis, and pathophysiology of right heart dysfunction and failure in patients with HFpEF. Finally, potential treatment strategies, important knowledge gaps and future directions regarding the right side in HFpEF are discussed.

Original languageEnglish
Pages (from-to)16-37
Number of pages22
JournalEuropean Journal of Heart Failure
Volume20
Issue number1
DOIs
Publication statusPublished - Jan 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2017 The Authors. European Journal of Heart Failure © 2017 European Society of Cardiology

Fingerprint

Dive into the research topics of 'Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology'. Together they form a unique fingerprint.

Cite this